AstraZeneca

Incesu explains why NMOSD is so often misdiagnosed and what it will take for rare diseases to gain a stronger foothold within national health strategies

The country president outlines how the company is partnering with the government and healthcare institutions to advance patient care

The EVP – International shares how the company is working to deliver healthcare that is inclusive, impactful and future-focused